title: New cyclosporine derivative SDZ IMM 125: in vitro and in vivo pharmacologic effects and toxicologic evaluation.
authors.affiliation: Preclinical Research, Sandoz Pharmaceutical Ltd, Basel, Switzerland.
authors.forename: P C
authors.initials: PC
authors.lastname: Hiestand
authors.forename: M
authors.initials: M
authors.lastname: Gräber
authors.forename: U
authors.initials: U
authors.lastname: Hurtenbach
authors.forename: P
authors.initials: P
authors.lastname: Herrmann
authors.forename: S
authors.initials: S
authors.lastname: Cammisuli
authors.forename: B P
authors.initials: BP
authors.lastname: Richardson
authors.forename: M K
authors.initials: MK
authors.lastname: Eberle
authors.forename: P
authors.initials: P
authors.lastname: Donatsch
authors.forename: B
authors.initials: B
authors.lastname: Ryffel
authors.forename: J F
authors.initials: JF
authors.lastname: Borel
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy; D016572:Cyclosporine / Q000494:pharmacology / Q000633:toxicity; D003524:Cyclosporins / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D007166:Immunosuppressive Agents / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D051381:Rats
chemical_list: D003524:Cyclosporins; D007166:Immunosuppressive Agents; D016572:Cyclosporine; C075935:SDZ IMM 125